CBD_SBIR_243_PhaseI_v2.pdf
PDF 432 KB Posted
- Solicitation number
- CBD243-001
About this file
This document is the FY24.3 Small Business Innovation Research (SBIR) Proposal Submission Instructions for the Chemical and Biological Defense (CBD) Program, managed by the Joint Science and Technology Office for Chemical and Biological Defense (JSTO CBD) at the Defense Threat Reduction Agency (DTRA).
The CBD SBIR Program seeks innovative technologies to improve defensive capabilities against chemical and biological warfare threats for the U.S. Military. Research focus areas include chemical and biological detection (point and stand-off), individual and collective protection, decontamination, medical countermeasures, medical diagnostics, digital battlespace management, and wearable technologies. Phase I awards have a maximum value of $204,582 for up to six months of performance. Proposals must be submitted exclusively through the Defense SBIR/STTR Innovation Portal (DSIP) at https://www.dodsbirsttr.mil and consist of five volumes: proposal coversheet, technical volume (not to exceed 20 pages with minimum 10-point font), cost volume, Company Commercialization Report, and supporting documents including a Contractor Certification Regarding Prohibition on Contracting for Certain Telecommunications and Video Surveillance Services or Equipment. Phase II proposals may be submitted no sooner than five months after Phase I contract award and require a commercialization plan and 24-month budget. Offerors must complete Fraud, Waste, and Abuse training and disclose all foreign nationals, green card holders, and dual citizens involved in the project. Research involving human subjects or animal use is prohibited in Phase I but permitted in Phase II, subject to DoD-level approvals from the U.S. Army Medical Research and Development Command and the Defense Threat Reduction Agency's Research Oversight Board. The CBD SBIR Program does not currently participate in Direct to Phase II or Technical and Business Assistance programs. FY24.3 approved topics include three active topics: CBD243-001 (Compact Hyperspectral micro-Raman Aerosol Detector), CBD243-002 (Multiplexed Agent Detector with Cavity Ring-Down Spectroscopy), and CBD243-003 (Room Temperature PbS/PbSe Photoconductive Detector for Mid-Infrared Wavelength Region), while CBD243-004 has been removed.
View the file
Other files
| File | Type | Posted |
|---|---|---|
| CBD243-001.pdf |
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Cleared for Public Release
VERSION 2
CBD SBIR - 1
CHEMICAL AND BIOLOGICAL DEFENSE PROGRAM
FY24.3 Small Business Innovation Research (SBIR)
Proposal Submission Instructions
The approved FY24.3 topics included in the Chemical and Biological Defense (CBD) Small Business Innovation Research (SBIR) Program is provided in this document. Offerors responding to this Announcement must follow all general instructions provided in the Department of Defense (DoD) Program Announcement, as well as the CBD SBIR Instructions provided below, detailing specific CBD SBIR program requirements.
Proposers are encouraged to thoroughly review the DoD Program Broad Agency Announcement (BAA), as well as register for the DoD SBIR/STTR Innovation Portal (DSIP) Listserv to remain apprised of important programmatic and contractual changes.
• The DoD Program BAA: https://www.dodsbirsttr.mil/submissions/solicitation-documents/active-solicitations. Be sure to select the tab for the appropriate BAA cycle.
• Register for the DSIP Listserv at: https://www.dodsbirsttr.mil/
Please read the entire DoD Announcement and these CBD SBIR instructions carefully prior to submitting your proposal. Important programmatic changes have been incorporated as required by the SBIR and STTR Extension Act of 2022 (Pub. L. 117-183). Also, go to https://www.sbir.gov/about/about-sbir#sbir-policy-directive to read the SBIR/STTR Policy Directive issued by the U. S. Small Business Administration (SBA).
INTRODUCTION
In response to Congressional interest in the readiness and effectiveness of U.S. Nuclear, Biological and Chemical (NBC) warfare defenses, Title XVII of the National Defense Authorization Act for Fiscal Year 1994 (Public Law 103-160) requires the Department of Defense (DoD) to consolidate management and oversight of the Chemical and Biological Defense Program (CBDP) into a single office – Office of the Assistant Secretary of Defense for Nuclear, Chemical and Biological Defense Programs. The Joint Science and Technology Office for Chemical and Biological Defense (JSTO CBD), located at the Defense Threat Reduction Agency (DTRA), provides the management for the Science and Technology component of the Chemical and Biological Defense Program. Technologies developed under the Small Business Innovation Research (SBIR) Program have the potential to transition to the Joint Program Executive Office for Chemical Biological Radiological and Nuclear Defense (JPEO CBRND) if the appropriate level of technology maturity is demonstrated. The JSTO CBD Science & Technology programs and initiatives improve defensive capabilities against Chemical and Biological Weapons of Mass Destruction. The SBIR portion of the CBD Program is managed by JSTO CBD.
The mission of the Chemical and Biological Defense Program is to ensure that the U.S. Military has the capability to operate effectively and decisively in the face of chemical or biological warfare threats at home or abroad. Numerous factors continually influence the program and its technology development priorities. Improved defensive capabilities are essential in order to mitigate the overall impact of chemical and biological threats. The U.S. military requires the finest state-of-the-art equipment and instrumentation available to permit our Joint Force to ‘detect to warn’ and avoid contamination, if possible – and to be able to sustain operations in a potentially contaminated environment. Further information is available at the Office of the Assistant Secretary of Defense for Nuclear, Chemical, and Biological Defense Programs homepage at https://www.acq.osd.mil/ncbdp/cbd/.
The overall objective of the CBD SBIR Program is to improve the transition or transfer of innovative Chem-Bio technologies to the end user – the Joint Force – in addition to commercializing technologies https://www.dodsbirsttr.mil/submissions/solicitation-documents/active-solicitations https://www.dodsbirsttr.mil/submissions/solicitation-documents/active-solicitations https://www.dodsbirsttr.mil/submissions/login https://www.sbir.gov/about/about-sbir#sbir-policy-directive https://www.sbir.gov/about/about-sbir#sbir-policy-directive https://www.acq.osd.mil/ncbdp/cbd/
CBD SBIR - 2
within the private sector for mutual benefit. The CBD SBIR Program targets those technology efforts that maximize a strong defensive posture in a biological or chemical environment using passive and active means as deterrents. These technologies include chemical and biological detection for both point and stand-off capabilities; individual and collective protection; hazard mitigation (decontamination); medical pre-treatments (e.g., vaccine development and delivery); medical therapeutics (chemical and biological countermeasures); medical diagnostics; Digital Battlespace Management (a.k.a., information systems technology) to include but not limited to modeling and simulation (e.g., meteorological dispersion), disease surveillance, data fusion, and health & human effects to include wearable technologies.
All proposals submitted to the CBD SBIR program must comply to the terms of this Announcement.
CBD SBIR reserves the right to limit awards under any topic, and only those proposals of superior scientific and technical quality, as determined by Technical Evaluation Team and the CBD SBIR program office will be funded. CBD SBIR reserves the right to withdraw from negotiations at any time prior to contract award. The Government may withdraw from negotiations at any time for any reason to include matters of national security (foreign persons, foreign influence or ownership, or other related issues).
Use of Foreign Nationals (also known as Foreign Persons), Green Card Holders, and Dual Citizens
See the “Foreign Nationals” section of the DoD SBIR Program Announcement for the definition of a Foreign National (also known as Foreign Persons).
It is the responsibility of ALL offerors proposing who use foreign nationals, green-card holders, or dual citizens, to disclose this information regardless of whether the topic is subject to export control restrictions. Offerors MUST identify any foreign nationals or individuals holding dual citizenship expected to be involved on this project as a direct employee, subcontractor, or consultant. For these individuals, specify their country of origin, the type of visa or work permit under which they are performing and an explanation of their anticipated level of involvement on the project. You may be asked to provide additional information during contract negotiations in order to verify the foreign citizen’s eligibility to participate on a SBIR contract. Supplemental information provided in response to this paragraph will be protected in accordance with the Privacy Act (5 U.S.C. 552a), if applicable, and the Freedom of Information Act (5 U.S.C. 552(b)(6)).
Proposers responding to a topic in this BAA must follow all general instructions provided in the Department of Defense (DoD) SBIR Program BAA, paying special attention to the new requirements under the SBIR and STTR Extension Act of 2022 (Pub. L. 117-183). The Chemical and Biological Defense SBIR Program requirements are provided in the instructions below.
Specific questions pertaining to the administration of the Chemical and Biological Defense SBIR Program and these proposal preparation instructions should be directed to: Ms. Abigail L. Roots, Chemical and Biological Defense SBIR/STTR Program Manager, JSTO CBD, at dtra.belvoir.rd.mbx.jsto-cbd-chem-bio-defense-sbir@mail.mil.
mailto:dtra.belvoir.rd.mbx.jsto-cbd-chem-bio-defense-sbir@mail.mil
CBD SBIR - 3
PHASE I PROPOSAL GUIDELINES
The Defense SBIR/STTR Innovation Portal (DSIP) is the official portal for DoD SBIR/STTR proposal submission. Firms are required to submit proposals via DSIP; proposals submitted by any other means will be disregarded. Detailed instructions regarding registration and proposal submission are provided in the DoD SBIR Program BAA.
Proposal Coversheet (Volume 1) The proposal coversheet must follow the instructions and requirements provided in the DoD SBIR Program BAA.
The offeror shall certify that to the best of its knowledge and belief, its eligibility information under the SBIR Program is accurate, complete, and current as of the date of the offer.
Technical Volume (Volume 2) The technical volume is not to exceed 20-pages and must follow the formatting requirements provided in the DoD SBIR Program BAA. No other information included in the other proposal volumes will count against the 20-page Proposal Technical Volume page limit. Pages provided exceeding this length will not be considered for review. The proposal must not contain any font type smaller than 10-point font size (except as a legend on reduced drawings, but not in the tables).
The maximum dollar amount for a Phase I proof-of-concept/feasibility study is $204,582.00 for a period of performance (PoP) of up to six (6) months. The CBD SBIR Program will not accept proposals exceeding $204,582.00 for the Phase I effort.
The entire proposal submission must be through the Defense SBIR/STTR Innovation Portal (DSIP) located at: https://www.dodsbirsttr.mil. Any questions pertaining to the DoD SBIR/STTR submission process and system should be directed to DSIP Support: DoDSBIRSupport@reisystems.com.
Selection of Phase I proposals will be based upon the three (3) evaluation criteria as mentioned in the DoD BAA. The CBD SBIR Program reserves the right to limit awards under any topic, and only those proposals of superior scientific and technical quality deemed by the Technical Evaluation Team will be funded. All SBIR contract awards, both Phase I and Phase II, are subject to availability of funding.
The brief Period of Performance available for a Phase I project precludes plans that include research involving human or animal subjects as all associated DoD requirements and the necessary approvals must be strictly adhered to and require considerable coordination and significant time for final protocol approvals. See “Research Involving Human Subjects, Biospecimens, and/or Animal Use,” below for further information.
Proposals not conforming to the terms of this Announcement, and any unsolicited proposals, will not be considered. All awards are subject to the availability of funding and successful completion of contract negotiations. The Chemical and Biological Defense Program is not responsible for any funds expended by the proposer prior to contract award.
Cost Volume (Volume 3) The Cost Volume must follow all instructions and requirements provided in the DoD SBIR Program BAA. The Phase I Base amount must not exceed $204,582.00. Total Base cost for Phase I must be clearly identified on the Proposal Cover Sheet (Volume 1) and in Volume 3.
https://www.dodsbirsttr.mil/ mailto:DoDSBIRSupport@reisystems.com
CBD SBIR - 4
Company Commercialization Report (CCR) (Volume 4) Completion of the CCR is required and included in Volume 4 of the DSIP portal. Please refer to the DoD SBIR Program BAA for full details on this requirement. Information contained in the CCR will not be considered by the Chemical and Biological Defense Program in the proposal evaluations.
Supporting Documents (Volume 5) Please note proposals are required to include additional forms, as listed below. Failure to submit the following document to Volume 5 will automatically result in disqualification of the Small Business Concern (SBC) from receiving an SBIR award for that proposal:
1. Contractor Certification Regarding Provision of Prohibition on Contracting for Certain Telecommunications and Video Surveillance Services or Equipment
Offerors are welcome to provide Supporting Documents in this section, however these documents will not be considered by the Chemical and Biological Defense Program in the proposal evaluations.
Fraud, Waste and Abuse (Volume 6) All offerors must complete the Fraud, Waste, and Abuse training through the DSIP portal (https://www.dodsbirsttr.mil). Please follow the guidance provided via DSIP to complete the required training prior to proposal submission.
To Report Fraud, Waste, or Abuse, please contact:
DoD Inspector General (IG) Fraud, Waste & Abuse Hotline: (800) 424-9098 hotline@dodig.mil
Additional information on Fraud, Waste and Abuse may be found in the DoD Announcement.
Disclosures of Foreign Affiliations or Relationships to Foreign Countries (Volume 7) Small business concerns must complete the Disclosures of Foreign Affiliations or Relationships to Foreign Countries webform in Volume 7 of the DSIP proposal submission. Please be aware that the Disclosures of Foreign Affiliations or Relationships to Foreign Countries WILL NOT be accepted as a PDF Supporting Document in Volume 5 of the DSIP proposal submission. Do not upload any previous versions of this form to Volume 5. For additional details, please refer to the DoD SBIR Program BAA.
DIRECT TO PHASE II PROPOSAL GUIDELINES
The Chemical and Biological Defense SBIR Program is not currently participating in Direct to Phase II topics.
PHASE II PROPOSAL GUIDELINES
Offerors may only submit a Phase II proposal after receipt of a Phase I award.
Phase II is the demonstration of the technology that was found feasible in Phase I. A Phase II proposal may not be submitted until sufficient Phase I progress can be evaluated and assessed, and the PoP is nearing completion. The SBC may not submit a Phase II proposal sooner than five (5) months from the date of the Phase I contract award, and upon receiving instructions from the CBD program office.
All Phase II proposal submissions must be submitted on the DSIP portal:
https://www.dodsbirsttr.mil.
https://www.dodsbirsttr.mil/ mailto:hotline@dodig.mil https://www.dodsbirsttr.mil/
CBD SBIR - 5
At the DSIP website, Phase II proposals MUST be submitted to ‘CBD SBIR’ regardless of which DoD contracting office negotiated and awarded the Phase I contract. Additional instructions regarding the Phase II proposal submission process including submission key dates will be provided to Phase I awardees after the Phase I contract is awarded.
The Phase II proposal must include a concise summary of the Phase I project including the specific technical problem or opportunity addressed in the proposal. The proposal must also include an objective statement, the type of research conducted, findings and/or results of the research, and technical feasibility of the technology. Due to limited funding, the CBD SBIR program reserves the right to limit awards under any topic and only proposals considered to be of superior quality will be funded.
All proposers are required to submit a commercialization plan that describes the SBC’s marketing and manufacturing approach to developing the technology. The Offeror is required to submit a budget for the entire 24-month Phase II Period of Performance. During contract negotiation, the Contracting Officer may require a Cost Volume for a base year and an option year; thus, proposers are advised to be aware of this possibility. These costs must be submitted using the Cost Volume format within the DSIP website.
The total proposed amount should be indicated on the Proposal Cover Sheet as the Proposed Cost. At the Contracting Officer’s discretion, Phase II projects may be evaluated for technical progress prior to the end of the base year (year one) in order to determine whether to extend the funding for the option year (year two).
The CBD SBIR Program is committed to minimizing the funding gap between Phase I and Phase II activities. The CBD SBIR Program typically funds a cost-plus fixed fee Phase II award at the discretion of the Contracting Officer but may award a firm fixed price contract.
It is recommended that Phase II awardees have a Defense Contract Audit Agency (DCAA) approved accounting system. If you do not have a DCAA approved accounting system, this could delay/prevent a Phase II contract award. Visit https://www.dcaa.mil/Customers/Small-Business for more information on DCAA approved accounting systems.
DISCRETIONARY TECHNICAL AND BUSINESS ASSISTANCE (TABA)
Currently, the CBD SBIR Program does not participate in the Technical and Business Assistance (TABA) Program.
EVALUATION AND SELECTION
All proposals will be evaluated in accordance with the evaluation criteria listed in the DoD SBIR Program
BAA.
Offerors will be notified of selection or non-selection within the 90-day window requirement at the close of the BAA. The CBD SBIR Program Office will notify the firm via e-mail to the firm’s Corporate Official (Business Point of Contact) and Principal Investigator, as listed on the Cover Page of the proposal.
The firm may submit an email request to the CBD SBIR/STTR inbox, dtra.belvoir.rd.mbx.jsto-cbd-chem-bio-defense-sbir@mail.mil, to request a technical debrief. The CBD SBIR Program Office will send a debriefing statement within 30-days of the request. The debriefing statement will only be provided to the Corporate Official and the Principal Investigator, as listed on the Cover Page of the proposal. Requests made by the offeror for further information will not be provided.
Refer to the DoD SBIR Program BAA for guidance concerning protests. As further prescribed in FAR 33.106(b), FAR 52.233-3, Protests after Award should be submitted to Ms. Abigail L. Roots, Chemical https://www.dcaa.mil/Customers/Small-Business
CBD SBIR - 6
and Biological Defense (CBD) SBIR/STTR Program Manager, Joint Science and Technology Office for Chemical and Biological Defense (JSTO CBD), dtra.belvoir.rd.mbx.jsto-cbd-chem-bio-defense-sbir@mail.mil.
RESEARCH INVOLVING HUMAN SUBJECTS, BIOSPECIMENS, AND/OR ANIMAL USE
Any research under a Phase I or Phase II contract involving human subjects, human anatomical substances (e.g., whole blood, cell lines, tissue), and/or animal use must undergo the regulatory review requirements per DoD Instruction 3216.02 and DoD Instruction 3216.01, respectively.
DoD-level review and approval of human and/or animal use are separate from, and in conjunction with the Institutional Review Board (IRB) and/or the Institutional Animal Care and Use Committee (IACUC).
CBD SBIR Projects Requiring Animal Subjects
Refer to the DoD Program BAA for Research Involving Animal Subjects.
Companies should plan carefully for any research involving animal subjects, in addition to the use of any chemical or biological warfare agents, and use of any agents associated with “Dual Use Research of Concern (DURC)”. The mandatory DoD level review of this research is typically a period of no greater than four (4) months.
Projects under CBD SBIR awards involving the use of animal subjects shall not be proposed for any Phase I Period of Performance but may be proposed during the Phase II proposal submission.
Written authorization to begin animal research under the applicable protocol(s) proposed as part of the CBD SBIR/STTR program will be issued after the contract award in the form of an approval memo from the U.S. Army Medical Research and Development Command (MRDC), Animal Care and Use Review Office (ACURO), and the Research Oversight Board (ROB) of the Defense Threat Reduction Agency (DTRA), both of which provide DoD compliance oversight to the CBD SBIR and STTR program office.
The offeror is expressly forbidden from using or subcontracting for the use of animals in any manner prior to these approvals. Furthermore, modifications to approved protocols require review and approval by the ACURO prior to implementation.
Non-compliance with these terms and conditions may result in withholding of funds and/or the termination of the award. The ACURO and DTRA ROB reviews are separate from, and in addition to the responsible Institutional Animal Care and Use Committee (IACUC) review(s). Further information may be required if the proposal is successful.
CBD SBIR Projects Requiring Human Subjects, Human Anatomical Substances, and/or Human Data
Refer to the DoD Program BAA for Research Involving Human Subjects and Recombinant DNA Molecules.
Companies should plan carefully for any research involving human subjects, human data, and/or human biospecimens (human anatomical substances; e.g., blood, saliva, tissue), to include cadaveric specimens, hereafter referred to as “research”, in addition to the use of any chemical or biological warfare agents, and use of any agents associated with “Dual Use Research of Concern (DURC)”. The mandatory DoD level review of this research is typically no greater than four (4) months.
CBD SBIR - 7
Projects under CBD SBIR awards involving the use of human subjects shall not be proposed for any Phase I Period of Performance but may be proposed during the Phase II proposal submission.
Written authorization to begin the research under the applicable protocol(s) proposed as part of the CBD SBIR/STTR program will be issued after the contract award in the form of an approval memo from the U.S. Army Medical Research and Development Command (MRDC), Office of Human Research Oversight (OHRO), and the Research Oversight Board (ROB) of the Defense Threat Reduction Agency (DTRA), both of which provide DoD compliance oversight to the CBD SBIR and STTR program office.
The offeror is expressly forbidden from beginning the research in any manner prior to these approvals.
Furthermore, modifications to approved protocols require review and approval by the OHRO prior to implementation.
Non-compliance with these terms and conditions may result in withholding of funds and/or the termination of the award. The OHRO and DTRA ROB reviews are separate from, and in addition to the responsible Institutional Review Board (IRB) review(s). Further information may be required if the proposal is successful.
CBD SBIR - 8
CBD SBIR 24.3 Topic Index
CBD243-001 Compact Hyperspectral micro-Raman Aerosol Detector
CBD243-002 Multiplexed Agent Detector with Cavity Ring-Down Spectroscopy (MADCaRS)
CBD243-003 A room temperature PbS/PbSe photoconductive detector for the mid-infrared wavelength region.
CBD243-004 Technologies for the quick and easily detection, decontamination and to prevent the spread of Novichok Contamination
CBD SBIR - 9
CBD243-001 Compact Hyperspectral micro-Raman Aerosol Detector
OUSD (R&E) CRITICAL TECHNOLOGY AREA(S): Biotechnology
OBJECTIVE: Develop a micro-Raman aerosol detector that meets the size, weight, power, and cost (SWaP-C) requirements for UAV-delivery and is capable of semi-continuously collecting and analyzing particles from the ambient atmosphere using hyperspectral Raman spectroscopy. The system may use additional spectroscopic or light scattering techniques to achieve an adequate measurement rate and should be able to store raw data and provide processed data for integration into data fusion systems.
DESCRIPTION: Micro-Raman spectroscopy is considered an attractive method for early warning of chemical and biological threats because of its broad applicability—including detection of aerosols, explosives, and pharmaceuticals—adaptability, and lack of sample preparation [1]. Unfortunately, the adoption of automated micro-Raman spectroscopy is limited by several challenges that hinder its utility.
For example, luminescence is known to overwhelm signals from biological or mineral particles; spectra from heterogeneous, or mixed composition, particles can be difficult to interpret; high laser intensity can alter the spectra of particles; and “long” analyses (seconds) for smaller particles (< 10 µm) has slowed the speed of identification. Moreover, a hyperspectral approach—e.g., line-scanning [2] or fiber-array [3]—is needed to obtain spectra from adequate numbers of particles.
Recent technological advancements make early warning applications of Raman spectroscopy more attainable. These include decreases in laser size, weight, and power for Raman spectroscopy systems; the availability of compact energy efficient deep-UV lasers [4]; and the use of Raman and fluorescence from deep-UV excitation to aid in identification [5] Other developments such as the use of shifted-excitation Raman difference spectroscopy [6] time-resolved spectroscopy [7] also enhance Raman signals relative to background. A early version of this technology is the REBS (Battelle, Dayton, OH), which uses electrostatic precipitation coupled to a line-scanning hyperspectral Raman system, though compact, UAV-use requires even greater reduction in SWaP-C [2].
It is feasible to envisage the development of a small, lightweight hyperspectral micro-Raman aerosol detector-airborne (HRAD-A). The HRAD-A should be able to measure Raman spectra of individual aerosol particles as small as 500 nm (e.g., polystyrene latex spheres) and analyze over 150 one-μm size particles sampled at an atmospherically relevant concentration in 15 minutes (e.g., ammonium nitrate, bacillus spores, paracetamol). The HRAD-A should provide greater situational awareness and capability of force protection by providing information on a wide range of harmful airborne particles [8], including chemical or biological agents and particles affecting visibility and/or communications. The US Army Training and Doctrine Command (TRADOC) Force Operating Capabilities calls for robotic platforms that provide environmental risk assessment from an established baseline [9], and can allow for remote CBRN reconnaissance [10, 11]. These elements should be able to be integrated with battlefield information management and data fusion systems to provide actionable information [9].
The HRAD-A should be designed to be a portable, low SWaP-C sensor capable of being distributed throughout an area of operations to achieve an increased situational understanding and provide CBRN and environmental background surveillance data as needed. For example, a sensor might be placed in an austere location by a UAV and then run off a solar panel for remote surveillance. Additionally, a system with open-source hardware and software that can be integrated into data-fusion systems ensures future compatibility as part of the multi-domain operations battlespace. Further, if the system is modular—i.e., the optical path can be switched—it can enable integration with future systems.
PHASE I: Design the HRAD-A to sample and analyze ambient aerosol particles leveraging hyperspectral Raman spectroscopy from multiple particles at a time. Use of other techniques to aid in
CBD SBIR - 10
discrimination, such as fluorescence (excited by the same laser for the Raman), is encouraged. Particles of interest include such as polystyrene latex spheres (0.5 μm), 1 µm bacterial/mold spores, chemical simulants, ammonium nitrate, and pharmaceuticals. Minimum specification of the design includes operating from DC 8-16V, a size of < 3L, weight of < 10kg, and sufficient power for 4 hours of operation.
The aerosol system should be able to run continuously for several days connected to mains power without human intervention. The deliverables for Phase I will include: the design for the HRAD-A including specific concept details; a description of why the HRAD-A is likely to perform as desired; proof of concept results, if obtained; how this concept can be prototyped; and criteria Phase II validation.
PHASE II: In Phase II a prototype will be fabricated and validated. Deliverables will include a prototype capable of collecting aerosol particles measuring Raman spectra from polystyrene latex spheres as small as 500nm, collecting and measuring Raman spectra from 150 particles in 15 minutes, and demonstration of semi-continuous sampling in the ambient outdoor environment, in accordance with the validation success criteria developed in Phase I.
PHASE III: In Phase III a low-SWaP-C HRAD-A will be provided for long-term surveillance for ambient aerosol hazards and for measuring particles which affect visibility and communications. The desired HRAD-A could also be used (on a UAV/UGV) to investigate areas for potential hazards, e.g., chem/bio agents. Commercialization of the technologies will also be pursued. The ability of the optical pathway to be used for other purposes also has significant utility. Employed in a handheld manner, Raman spectroscopy can be used to non-destructively determine the composition of materials inside plastic bags and some plastic and glass containers.
REFERENCES:
1. Silge, A., et al., Trends in pharmaceutical analysis and quality control by modern Raman spectroscopic techniques. TrAC Trends in Analytical Chemistry, 2022. 153: p. 116623.
2. Doughty, D.C. and S.C. Hill, Automated aerosol Raman spectrometer for semi-continuous sampling of atmospheric aerosol. Journal of Quantitative Spectroscopy and Radiative Transfer, 2017. 188: p. 103–117.
3. Frosch, T., et al., Fiber-Array-Based Raman Hyperspectral Imaging for Simultaneous, Chemically-Selective Monitoring of Particle Size and Shape of Active Ingredients in Analgesic Tablets. Molecules, 2019. 24(23): p. 4381.
4. Feng, K., et al., Simple and compact high-power continuous-wave deep ultraviolet source at 261nm based on diode-pumped intra-cavity frequency doubled Pr:LiYF4 green laser. Optics Express, 2023. 31(12): p. 18799-18806.
5. Bhartia, R., et al., Perseverance’s Scanning Habitable Environments with Raman and Luminescence for Organics and Chemicals (SHERLOC) Investigation. Space Sci. Rev., 2021.
217(58): p. 1-115).
6. Lorenz, B., et al., Comparison of conventional and shifted excitation Raman difference spectroscopy for bacterial identification. Journal of Raman Spectroscopy, 2022. 53(7): p. 1285- 1292.
7. Fau, A., et al., Time-resolved Raman and luminescence spectroscopy of synthetic REE-doped hydroxylapatites and natural apatites. American Mineralogist, 2022. 107(7): p. 1341-1352.
8. Pope III, C.A., et al., Lung Cancer, Cardiopulmonary Mortality, and Long-term Exposure to Fine Particulate Air Pollution. JAMA, 2002. 287(9): p. 1132-1141.
9. TRADOC, TP 525-66: Force Operating Capabilities. 2008.
10. Army, U., Field Manual 3.0: Operations. 2023.
11. CJCS, JP 3-11: Operations in Chemical, Biological, Radiological, and Nuclear Environment.
2018.
CBD SBIR - 11
KEYWORDS: Raman, detection, chem-bio, atmosphere, UAV
CBD SBIR - 12
CBD243-002 Multiplexed Agent Detector with Cavity Ring-Down Spectroscopy (MADCaRS)
OUSD (R&E) CRITICAL TECHNOLOGY AREA(S): Biotechnology
OBJECTIVE: Develop an infrared cavity ring-down spectroscopy-based system possessing a large dynamic range for the rapid, sensitive, and selective identification of vapor phase and aerosol phase chemical warfare agents (CWA).
DESCRIPTION: Vapor phase detection techniques of CWAs are often not specific or are restricted to very specific and/or narrow concentration ranges, causing frequent false positive and dynamic range issues. Additionally, current commercial technology that has greater specificity or a larger dynamic range are typically benchtop systems and not portable for the warfighter. Vapor and aerosol challenges are not static and can continuously evolve both in type of challenge and in concentration; therefore, there is a need for a robust system that can detect chemical warfare agents and other toxic industrial compounds (TICs) and can be carried by the warfighter. While some systems exist and claim to have a large dynamic range, the ability to detect a library of compounds, and are man-portable, no known man-portable systems exist that can provide rapid, sensitive, and selective chemical identification, even on unknown compounds outside of a pre-built library, over a large dynamic range. This infrared-based prototype will provide the warfighter with rapid feedback of any potential threats within the local vapor environment.
The goal of this project is to develop an infrared cavity ring-down spectroscopy-based system with a large dynamic range from 100 ppb to 1000 ppm of all traditional agents (VX, GB, and HD), potential for non-traditional agents (NTAs), TICs such as phosgene, ammonia, or cyanide, as well as aerosolized liquid CWA. The lower end of the dynamic range will be of focus for the CWAs whereas the higher end of the dynamic range will be the focus for the TICs. The final prototype must not be limited to this set of challenges and must be able to update detection algorithms for new compounds. The final prototype must be less than 10 pounds, less than 16 L in volume, and continuously read in at least 60 second intervals with capability to modify interval length. The final prototype must be completely contained (i.e. not require outside gases, etc.) and can run on battery (warfighter portable), shore power (leave in place/perimeter applications), or through the means necessary for an unmanned system. The form factor must be amenable to deployment in adverse environments with temperature and humidity fluctuations from 0C to 45C and from 0% relative humidity (RH) to 90% (or non-saturating at respective temperature range). The system must be able to clear back to baseline signal within five minutes. Additionally, the prototype must use artificial intelligence/machine learning (AI/ML) for library building and/or spectral matching to enhance detection capabilities.
PHASE I: Establish proof of concept by developing a bread-board device that clears down in the appropriate amount of time and can capture signal at or below 1 ppm of two CWA simulants at room temperature and approximately 50% RH. The signal capture must take no more than 60 seconds and provide a result. Identify optimized geometry for prototype and establish any logistic requirements for prototyping.
PHASE II: Demonstrate system feasibility meeting outlined requirements including environmental requirements across at least two different temperatures and two different relative humidities which includes laboratory method validation and assessment of instrumentation. The prototype must meet the concentration requirements for at least two of the listed compounds (including one CWA) and must have detectability within the range for all compounds listed with the target range for the CWAs on the lower end of the dynamic range and the range for the TICs at the higher end of the dynamic range. CWA testing must be completed in an approved surety laboratory. The sensitivity for each listed compound will be established. A user assessment will be conducted to identify general improvements.
CBD SBIR - 13
PHASE III: Continued development and assessment at remaining temperatures and humidity levels and optimization of user interface. Finalize design/form factor for commercialization. Conduct final user assessment to incorporate modifications to design.
PHASE III DUAL USE APPLICATIONS: This technology would be useful to civilian first responders, leave-in-place detectors at large social events, or in perimeter monitoring around various municipal facilities for vapor leakage.
REFERENCES:
1. Zhang, Z.-T.; Cheng, C.-F.; Sun, Y.; Liu, A.-W.; Hu, S.-M., Cavity ring-down spectroscopy based on a comb-locked optical parametric oscillator source. Optics Express 2020, 28 (19), 27600-27607.
2. Dhall, S.; Mehta, B. R.; Tyagi, A. K.; Sood, K., A review on environmental gas sensors:
Materials and technologies. Sensors International 2021, 2, 100116.
3. Maity, A.; Maithani, S.; Pradhan, M., Cavity Ring-Down Spectroscopy: Recent Technological Advancements, Techniques, and Applications. Analytical Chemistry 2021, 93 (1), 388-416.
4. Cotterell, M. I.; Knight, J. W.; Reid, J. P.; Orr-Ewing, A. J., Accurate Measurement of the Optical Properties of Single Aerosol Particles Using Cavity Ring-Down Spectroscopy. The Journal of Physical Chemistry A 2022, 126 (17), 2619-2631.
KEYWORDS: CRDS, IR, vapor, agent, rapid, aerosol
CBD SBIR - 14
CBD243-003 A room temperature PbS/PbSe photoconductive detector for the mid-infrared wavelength region.
OUSD (R&E) CRITICAL TECHNOLOGY AREA(S): Biotechnology
OBJECTIVE: Develop a room temperature photoconductive detector for the mid-infrared (2 to 4.5 µm) wavelength region based on lead salt detection elements.
DESCRIPTION: The chemical and biological defense community has the need for a small lightweight sensor for detection of chemical/biological agents and simulants. Infrared absorption spectroscopy has proven to be a very useful tool in the detection and identification of airborne chemicals and aerosols.
Pattern recognition is used to compare the infrared spectrum of library molecules against the infrared spectra of airborne contaminants. In particular chemical warfare agents and toxic industrial chemicals have distinctive absorption lines in the infrared region. Infrared spectroscopy has been used to detect chemicals at very low concentrations. Infrared spectroscopy also holds the promise of low false alarm rates due to the spectral pattern matching over a large number of spectral bins. The size, weight, and power requirements of current infrared spectrometers have limited their utility in field environments.
Current infrared spectrometers are too expensive to be deployed in large numbers.
Lead sulfide (PbS) is one of the oldest and most commonly used materials in use for the fabrication of infrared detectors. PbS and lead selenide (PbSe) detector cells make use of the photoconductive effect in which electrical resistance decreases with the application of infrared radiation. PbS and PbSe photoconductive detectors have high detection performance and fast response. They also have the advantage of room temperature operation. PbS and PbSe are very good candidates to fill the existing gap in the photonic and uncooled infrared detectors sensitive to the MWIR photons. Lead Salt detectors are a serious alternative to others uncooled technologies in the low cost infrared detection market. The number of potential applications is very large and includes infrared imagers, enhanced vision systems, and chemical/biological sensors.
Uncooled detectors will likely dominate the majority of the future IR detection applications. Considerable advances have taken place with thermal detectors in recent years. However it is not clear that thermal detectors are the best technology at the shorter wavelengths in the mid-infrared region. New methods of processing PbS and PbSe based on silicon technology are compatible with standard CMOS circuitry. The compatibility with CMOS allows for easy integration with electronic circuitry and fabrication based on existing lithographic methods.
The goal of this effort is to examine innovative methods for fabrication of detectors based on lead salts and to examine methods for manufacturing of polycrystalline PbS and/or PbSe with good electro optical characteristics. In particular three areas need to be addressed. 1) In Chem/Bio applications PbS/PbSe detectors will be required to detect infrared radiation over a fairly large spectral range (2 to 4.5 µm).
Uncooled operation of the detector over this entire wavelength region will require some care. The use of external coolers is discouraged. 2) The fabrication of the new photoconductive detectors will need to be compatible with existing CMOS technology to allow for easy integration with electrical components and to minimize noise and signal loss associated with non-ideal interfaces to readout electronics. 3).
Commercially available PbS/PbSe detectors are known to possess a non-linear response to the irradiance of MWIR radiation illuminating the detector. This non-linear response severely limits the utility of PbS/PbSe detectors in spectroscopic applications. The new fabrication method will need to minimize this non-linearity.
CBD SBIR - 15
PHASE I: Examine new methods for the fabrication of PbS/PbSe photoconductive detectors. The new detector elements should have good detection capability over the entire 2 to 4.5 µm region of the spectrum at room temperature with no external cooling required. A detectivity (D*) of 10^10 Jones or better is desired over the entire spectral range. The new detector should be compatible with CMOS fabrication. The non-linearity of the new detector with response to the irradiance of MWIR radiation illuminating the detector should be minimized. Design a fabrication process for improved photoconductive detectors based on lead salts. Perform necessary experiments as needed.
PHASE II: Based on the results of the Phase I effort, fabricate a PbS/PbSe photoconductive detector array that is suitable for spectroscopic application. The array should have at least 256 elements (16x16) with spacing and size suitable for spectroscopic applications. The detector elements should have a detectivity (D*) of 10^10 Jones or better. The detectors should be able to detect mid-IR radiation over the 2 to 4.5 µm region of the spectrum at room temperature with no external cooling. Design and build all necessary readout electronics. Test and characterize the system. Use the results of the testing to update the sensor design.
PHASE III DUAL USE APPLICATIONS: There are environmental applications for a small robust, chemical sensor. A rugged, inexpensive chemical sensor will benefit the manufacturing community by providing inexpensive monitoring of chemical processes. Also first responders such as Civilian Support Teams and Fire Departments have a critical need for a rugged, inexpensive sensor that can be transported to the field to test for possible contamination by CW agents.
REFERENCES:
1. G. Vergara, M. T. Montojo, M. C. Torquemada, M. T. Rodrigo, F. J. Sánchez, L. J. Gómez, R. M.
Almazán, M. Verdú, P. Rodríguez, V. Villamayor, M. Álvarez, J. Diezhandino, J. Plaza, and I.
Catalán, “Polycrystalline lead selenide: the resurgence of an old infrared detector”, Opto- Electronics Review, volume 15, number 2, pages 110-117 (2007).
2. J. Diezhandino, G. Vergara, G. Pérez, I. Génova, M. T. Rodrigo, F. J. Sánchez, M. C.
Torquemada, V. Villamayor, J. Plaza, I. Catalán, R. Almazán, M. Verdú, P. Rodríguez, L. J.
Gómez, and M. T. Montojo, “Monolithic integration of spectrally selective uncooled lead selenide detectors for low cost applications”, Appl. Phys. Lett., volume 83, issue 14, pages 2751- 2753 (2003).
3. Jun Ji, Jay P. Gore, Yudaya R. Sivathanu, and Jongmook Lim, “Fast infrared array spectrometer with a thermoelectrically cooled 160-element PbSe detector”, Rev. Sci. Instrum., volume 75, issue 2, pages 333-339 (2004).
4. D. E. Aspnes and M. Cardona, “Electro-Optic Measurements of PbS, PbSe, and PbTe”, Phys.
Rev., volume 173, issue 3, pages 714-728 (1968).
5. J.E. Freeman and G.M. Hieftje, “Interferometric Detection of Near-Infrared Nonmetal Atomic Emission from a Microwave-Induced Plasma”, Applied Spectroscopy, volume 39, issue 2, pages 211-361 (1985).
6. L. W. Kornaszewski, N. Gayraud, J. M. Stone, W. N. MacPherson, A. K. George, J. C. Knight, D. P. Hand, and D. T. Reid, "Mid-infrared methane detection in a photonic bandgap fiber using a broadband optical parametric oscillator," Opt. Express, volume 15, issue 18, pages 11219-11224 (2007).
7. T. H. Johnson, “Lead salt detectors and arrays: PbS and PbSe”, SPIE Proceedings, Vol. 443, Infrared Detectors, Society for Photo-Optical Instrumentation Engineers, pages 60-94. (1984).
8. Evangelos Theocharous, “Absolute linearity measurements on a PbS detector in the infrared”, Applied Optics, volume 45, issue 11, pages 2381-2386, (2006).
CBD SBIR - 16
9. S. Kouissa, M. S. Aida, and A. Djemel, “Surface states simulation model for photoconductors infrared detectors”, Journal of Materials Science: Materials in Electronics, volume 20, supplement 1, pages 400-406 (2009).
10. V. R. Mehta S. Shet, N. M. Ravindra, A. T. Fiory, and M. P. Lepselter, “Silicon-integrated uncooled infrared detectors: Perspectives on thin films and microstructures”, Journal of Electronic Materials, volume 34, number 5, pages 484-490 (2005).
KEYWORDS: Chemical Detection, uncooled infrared detector, lead selenide, lead sulfide, focal-plane-array
CBD SBIR - 17
CBD243-004 [Topic removed]
File details come from the government source that posted it. Updated .